Finance

Lists
B2RK34:BVMF
Bruker Corp
R$32.88
0.00%
(0.00) 1D
Nov 12, 10:33:11 AM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for B2RK34...
Mkt. cap
9.41B
Avg. vol.
2.00
Volume
0.00
52-wk high
R$32.40
52-wk low
R$17.38
Shares outstanding
152.72M
No. of employees
11K
Mkt. cap
9.41B
Avg. vol.
2.00
Volume
0.00
52-wk high
R$32.40
52-wk low
R$17.38
Shares outstanding
152.72M
No. of employees
11K
News stories
From web sources and news partners
Profile
Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis. It is headquartered in Billerica, Massachusetts, and is the publicly traded parent company of Bruker Scientific Instruments and Bruker Energy & Supercon Technologies divisions. In April 2010, Bruker created a Chemical Analysis Division under the Bruker Daltonics subsidiary. This division contains three former Varian product lines: ICPMS systems, laboratory gas chromatography, and GC-triple quadrupole mass spectrometer. In 2012, it sponsored the Fritz Feigl Prize, and since 1999 the company has also sponsored the Günther Laukien Prize. Wikipedia
About Bruker Corp
CEOFrank Laukien
Employees11.1K
Founded1960
HeadquartersBillerica, Massachusetts, United States
SectorHealth Care
Industry-
Websitebruker.com
Last report
Nov 4, 2026
Fiscal period
Q3 2026
$0.56 / $0.42
+34.61%beat
Revenue / Est. (USD)
874.00M / 865.19M
+1.02%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
977.20M
823.40M
838.50M
874.00M
Cost of goods sold
510.40M
428.20M
421.40M
443.70M
Cost of revenue
510.40M
428.20M
421.40M
443.70M
Research and development expenses
99.60M
101.30M
94.30M
92.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
244.20M
242.10M
238.90M
226.50M
Operating expense
402.50M
344.30M
334.30M
321.60M
Total operating expenses
912.90M
772.50M
755.70M
765.30M
Operating income
64.30M
50.90M
82.80M
108.70M
Other non operating income
-5.70M
3.00M
4.00M
1.50M
EBT including unusual items
67.00M
18.20M
-36.70M
-121.90M
EBT excluding unusual items
54.20M
47.30M
87.90M
103.70M
Income tax expense
37.80M
2.50M
14.20M
-12.20M
Effective tax rate
56.42%
13.74%
-38.69%
10.01%
Other operating expenses
58.70M
800.00K
1.10M
3.10M
Net income
26.00M
14.40M
-52.00M
-111.80M
Net profit margin
2.66%
1.75%
-6.20%
-12.79%
Earnings per share
0.59
0.31
0.49
0.56
Interest and investment income
4.60M
4.90M
11.30M
7.70M
Interest expense
-11.20M
-12.20M
-17.80M
-15.40M
Net interest expenses
-6.60M
-7.30M
-6.50M
-7.70M
Depreciation and amortization charges
-
-
-
-
EBITDA
122.40M
109.20M
140.80M
162.80M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps